A recent report published by Infinium Global Research
on contrast injector market provides in-depth analysis of segments and
sub-segments in global as well as regional contrast injector market. The study
also highlights the impact of drivers, restraints and macro indicators on the
global and regional contrast injector market over the short term as well as
long term. The report is a comprehensive presentation of trends, forecast and
dollar values of global contrast injector market. According to the report the
global contrast injector market is projected to grow at a CAGR of 7.1% over the
forecast period of 2018-2024.
Medical devices employed
for injecting radio-opaque contrast media into the body to enhance the
visibility of tissues for a medical imaging procedure is known as contrast
injectors. or, contrast injectors are used to enhance the quality of medical
imaging such as CT, MRI, PET/CT, and ultrasound. Over the years, with
ever-increasing technological sophistication, these contrast injectors have
evolved from manual injectors having manifolds with stop-cocks to automated
versions, providing added accuracy and advantages.
Global contrast injector
market is showing a positive trend of development around the globe. There are
many factors which are indicating a positive outlook of the market for medium and
long term. Factors such as a large number of approvals for contrast agents in
different geographies and an increasing number of public and private diagnostic
centers are helping to generate the sustainable demand for contrast injectors.
Additionally, the growing geriatric population, which is more prone to
cardiovascular and certain neurological disorders, it helps to focus in the region of clinical interest for better treatment is making it more favorable
in the medical sector for better treatment.
On the basis of region,
contrast injector market is fragmented into North America, Europe, Asia, and
the Rest of the World (RoW). North America is a leading player in this market
globally, due to the high adoption of contrast media injectors (CMI) in radiology
procedures by hospitals and clinicians as compared to other regions, high
prevalence of cardiovascular and neurological disorders. A large number of
people in these regions suffer from neurological and cardiovascular disorders,
propelling the market for contrast media injectors in the region. Medical connectors are with medical electronic
equipment, including diagnostic devices, surgical instruments, therapy
applications, dental applications, cardiac assist devices, and disposable
equipment etc.
Asia-Pacific region is
growing with the highest CAGR during the forecast period. Countries such as
China, India exhibit significant growth prospect in terms of the rapid increase in
the installation of medical imaging equipment and procedures. The growth of
contrast injector market in this region is attributed to economic growth in
this region, which has led to increased disposable income and consequently,
increased the affordability of sophisticated imaging technology, increasing
population of old people. Moreover, a large population base and growing
geriatric population, which is more prone to cardiovascular and certain
neurological disorders, would lead to a large potential patient base.
The report on global contrast injector market covers
segments such as product and application. On the basis of product, the global contrast injector market is categorized
into injector systems, consumables, and accessories. On the basis of
application, the global contrast injector market is categorized into radiology,
interventional cardiology, interventional radiology, and others.
The countries covered in the North America region
include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan,
India, South Korea, Malaysia, and among others. Moreover, Germany, U.K.,
France, Spain, and Rest of Europe are included in the European region. The U.S.
drives the growth in the North America region as it is the largest market in
the region. The Asia-Pacific region offers substantial potential for the
market growth owing to rapid growth in markets such as India and China. The
APAC region is projected to experience a growth at a CAGR of x.x% over the
period of 2018-2024.
The report provides profiles of the companies in the
global contrast injector market such as Bayer AG (Medrad Inc.), Bracco
Imaging S.P.A., Guerbet Group, Ulrich GmbH & Co. KG. ,
Nemoto Kyorindo Co., Ltd, Sino Medical-Device Technology Co., Ltd. (sinomdt),
Apollo RT Co., Ltd., Vivid Imaging, Angiodynamics (Navilyst
Medical, Inc) and GE Healthcare.
The report provides deep insights on demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the global contrast injector market. Moreover, IGR-Growth Matrix analysis given in the report brings insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of contrast injector market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the contrast injector market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings insight into the market share of the leading players. This report will help manufacturers, suppliers, and distributors of the contrast injector market to understand the present and future trends in this market and formulate their strategies accordingly.